XSLJZ
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XSLJZ, covering 2024-05-16 to 2024-05-16. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial [Phase 4]